Literature DB >> 34179898

Semi-parametric Estimation of Biomarker Age Trends with Endogenous Medication Use in Longitudinal Data.

Andrew J Spieker1, Joseph A C Delaney2, Robyn L McClelland3.   

Abstract

In cohort studies, non-random medication use can pose barriers to estimation of the natural history trend in a mean biomarker value-namely, the association between a predictor of interest and a biomarker outcome that would be observed in the total absence of biomarker-specific treatment. Common causes of treatment and outcomes are often unmeasured, obscuring our ability to easily account for medication use with assumptions commonly invoked in causal inference such as conditional ignorability. Further, without a high degree of confidence in the availability of a variable satisfying the exclusion restriction, use of instrumental variable approaches may be difficult to justify. Heckman's hybrid model with structural shift (sometimes referred to less specifically as the treatment effects model) can be used to correct endogeneity bias via a homogeneity assumption (i.e., that average treatment effects do not vary across covariates) and parametric specification of a joint model for the outcome and treatment. In recent work, we relaxed the homogeneity assumption by allowing observed covariates to serve as treatment effect modifiers. While this method has been shown to be reasonably robust in settings of cross-sectional data, application of this methodology to settings of longitudinal data remains unexplored. We demonstrate how the assumptions of the treatment effects model can be extended to accommodate clustered data arising from longitudinal studies. Our proposed approach is semi-parametric in nature in that valid inference can be obtained without the need to specify any component of the longitudinal correlation structure. As an illustrative example, we use data from the Multi-Ethnic Study of Atherosclerosis to evaluate trends in low-density lipoprotein by age and gender. Results from a collection of simulation studies, as well as our illustrative example, confirm that our generalization of the treatment effects model can serve as a useful tool to uncover natural history trends in longitudinal data that are obscured by endogenous treatment.

Entities:  

Keywords:  Biomarker; Cohort study; Endogenous; Longitudinal data; Multi-Ethnic Study of Atherosclerosis

Year:  2021        PMID: 34179898      PMCID: PMC8232347     

Source DB:  PubMed          Journal:  Obs Stud        ISSN: 2767-3324


  15 in total

1.  Trends in serum lipids and lipoproteins of adults, 1960-2002.

Authors:  Margaret D Carroll; David A Lacher; Paul D Sorlie; James I Cleeman; David J Gordon; Michael Wolz; Scott M Grundy; Clifford L Johnson
Journal:  JAMA       Date:  2005-10-12       Impact factor: 56.272

2.  Gender differences in LDL and HDL subfractions in atherogenic and nonatherogenic phenotypes.

Authors:  Ingrid Zitnanova; Stanislav Oravec; Maria Janubova; Katarina Konarikova; Monika Dvorakova; Lucia Laubertova; Maria Kralova; Martin Simko; Jana Muchova
Journal:  Clin Biochem       Date:  2020-02-05       Impact factor: 3.281

3.  Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994.

Authors:  A Ferrara; E Barrett-Connor; J Shan
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

4.  The age associations of blood pressure, cholesterol, and glucose: analysis of health examination surveys from international populations.

Authors:  Gitanjali M Singh; Goodarz Danaei; Pamela M Pelizzari; John K Lin; Melanie J Cowan; Gretchen A Stevens; Farshad Farzadfar; Young-Ho Khang; Yuan Lu; Leanne M Riley; Stephen S Lim; Majid Ezzati
Journal:  Circulation       Date:  2012-04-04       Impact factor: 29.690

5.  Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication use.

Authors:  Andrew J Spieker; Joseph A C Delaney; Robyn L McClelland
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-09-30       Impact factor: 2.890

6.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

7.  Associations of education with 30 year life course blood pressure trajectories: Framingham Offspring Study.

Authors:  Eric B Loucks; Michal Abrahamowicz; Yongling Xiao; John W Lynch
Journal:  BMC Public Health       Date:  2011-02-28       Impact factor: 3.295

8.  Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus.

Authors:  Giuseppina Russo; Basilio Pintaudi; Carlo Giorda; Giuseppe Lucisano; Antonio Nicolucci; Maria Rosaria Cristofaro; Concetta Suraci; Maria Franca Mulas; Angela Napoli; Maria Chiara Rossi; Valeria Manicardi
Journal:  Int J Endocrinol       Date:  2015-03-19       Impact factor: 3.257

9.  Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.

Authors:  Meredith S Duncan; Ramachandran S Vasan; Vanessa Xanthakis
Journal:  J Am Heart Assoc       Date:  2019-05-29       Impact factor: 5.501

10.  Gender differences in 7 years trends in cholesterol lipoproteins and lipids in India: Insights from a hospital database.

Authors:  Rajeev Gupta; Madhawi Sharma; Neeraj Krishna Goyal; Preeti Bansal; Sailesh Lodha; Krishna Kumar Sharma
Journal:  Indian J Endocrinol Metab       Date:  2016 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.